The 'Healthy Living' Trend Will Propel the Phytonutrient Ingredients Sector
LONDON, Aug. 15, 2018 /PRNewswire/-- Frost & Sullivan, the growth partnership company, announced today that it will host a live, complimentary Growth Innovation Leadership (GIL) briefing, "Growth Opportunities in the Global Phytonutrients Market" on
Increased consumer awareness of nutritional benefits coupled with advancements in extraction technologies across different ingredient types are key factors driving new growth opportunities in the global phytonutrients market. We anticipate the market to reach $7,385.2 million by 2022, with a CAGR of 7.6% between 2017 and 2022.
"The 'Living Healthy' trend among consumers will propel the carotenoids, phytosterols, vitamin E, polyphenols, and flavonoids markets," said Arun Ramesh. "Furthermore, the global dietary supplements segment is expected to grow the fastest over the next five years due to increased incidence of heart diseases and obesity, and a rise in supplement prescriptions by doctors."
For more information and to register for the webinar, please click here.
Join us to understand key technology and product developments impacting the global phytonutrients market.
Expert Insight You Don't Want to Miss:
The webinar will also be recorded and available for on-demand viewing at http://frost.ly/1ti.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
Press Contact:Jacqui HolmesCorporate CommunicationsFrost & Sullivan email@example.com
Subscribe to our Free Newsletters!
Take the quiz on Rabies and test your knowledge about this infection that can affect the brain ...
Pneumonitis usually refers to inflammation of lung tissue due to various non-infective causes such ...
Fremanezumab-vfrm is used as a preventive treatment for a migraine headache in adult patients. It ...View All